Search Results - "De La Orden, V."

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    Combined methylation of p16 and hMLH1 (CMETH2) discriminates a subpopulation with better prognosis in colorectal cancer patients with microsatellite instability tumors by Veganzones, S., Maestro, M. L., Rafael, S., de la Orden, V., Vidaurreta, M., Mediero, B., Espantaleón, M., Cerdán, J., Díaz-Rubio, E.

    Published in Tumor biology (01-05-2015)
    “…The aim of this study was to determine the frequency of p16 and hMLH1 genes simultaneous methylation in colorectal cancer patients with Microsatellite…”
    Get full text
    Journal Article
  5. 5

    Role of Fibroblast Growth Factor 23 (FGF23) in the Metabolism of Phosphorus and Calcium Immediately After Kidney Transplantation by Sánchez Fructuoso, A.I, Maestro, M.L, Calvo, N, De La Orden, V, Pérez Flores, I, Vidaurreta, M, Valero, R, Fernández-Pérez, C, Barrientos, A

    Published in Transplantation proceedings (01-11-2012)
    “…Abstract Introduction Persistence of inappropriately high serum levels of fibroblast growth factor-23 (FGF23), a recently discovered phosphaturic hormone, has…”
    Get full text
    Journal Article Conference Proceeding
  6. 6
  7. 7

    Influence of A9 Region Mutation in EphB2 Gene in the Prognosis of Patients with Colorectal Adenocarcinoma by Vidaurreta, M., Rafael, S., Veganzones, S., de la Orden, V., Fernández, C., Gómez-Casaseca, R., Cerdán, J., Maestro, M.

    Published in Annals of surgical oncology (01-05-2011)
    “…Background EphB2 is a transmembrane glycoprotein implicated in the regulation of cell growth, differentiation, and motility. It has been proposed as a tumor…”
    Get full text
    Journal Article
  8. 8

    Colorectal carcinoma prognosis can be predicted by alterations in gene p53 exons 5 and 8 by Vidaurreta, M., Maestro, M. L., Sanz-Casla, M. T., Rafael, S., Veganzones, S., de la Orden, V., Cerdán, J., Arroyo, M., Torres, A.

    “…Background and aims Gene p53 alteration is a genetic event described in the progression from adenoma to colorectal carcinoma. Most of the p53 mutations occur…”
    Get full text
    Journal Article
  9. 9

    Vascular endothelial growth factor gene polymorphisms in patients with colorectal cancer by Vidaurreta, M, Sánchez-Muñoz, R, Veganzones, S, Rafael, S, Gutiérrez, M, de-la-Orden, V, Fernández, C, Arroyo, M, Cerdán, F J, Maestro de las Casas, Ma Luisa

    “…Angiogenesis plays an important role in tumor progression. The vascular endothelial growth factor (VEGF) is an important regulator of angiogenesis. In the…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16

    567PROLE OF CIRCULATING TUMOR CELLS (CTC) IN STAGE III COLORECTAL CANCER (CRC) by Lezama, M. Sotelo, Sastre, J., Veganzones, S., Orden, V. De La, Viéitez, J.M., Alonso, V., Grávalos, C., Escudero, P., Vera, R., Aranda, E., Alfonso, P. García, Plazas, J. Gallego, López, C., Pericay, C., Arrivi, A., Lazcano, M.P. Vicente, Ballesteros, P., Elez, E., López-Ladrón, A., Díaz-Rubio, E.

    Published in Annals of oncology (01-09-2014)
    “…Abstract Aim: CTC detection has proved to be an independent prognostic factor in metastatic CRC. However, the prognostic role of CTC in early CRC has not been…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19

    A9 region in EPHB2 mutation is frequent in tumors with microsatellite instability. Analysis of prognosis by Rafael, Sara, Vidaurreta, Marta, Veganzones, Silvia, De La Orden, Virgnia, Mediero, Beatriz, Gutierrez, Maria Luisa, Maestro, Maria Luisa

    Published in Anticancer research (01-11-2013)
    “…The aim of the present study was to determine the relation of EPH tyrosine kinase receptor B2 (EPHB2) A9 region mutation and microsatellite instability (MSI);…”
    Get full text
    Journal Article
  20. 20